Regulation of HIV-1 transcription

Gene Expression

Volumn 8, Issue 2, 1999, Pages 67-84

  Roebuck, Kenneth A ^a   Saifuddin, Mohammed ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Activator protein 1; Chromatin; HIV 1; Long terminal repeat; Nuclear factor kappa B (NF B); Promoter; Tat; Transcription factors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR AP 1;

CHROMATIN; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LONG TERMINAL REPEAT; NONHUMAN; PROMOTER REGION; SHORT SURVEY; TRANSCRIPTION REGULATION; VIRUS GENOME; VIRUS TRANSCRIPTION;

BASE SEQUENCE; CHROMATIN; GENE EXPRESSION REGULATION, VIRAL; GENES, REGULATOR; HIV-1; HUMANS; PROMOTER REGIONS (GENETICS); TERMINAL REPEAT SEQUENCES; TRANSCRIPTION FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; RNA VIRUSES;

EID: 0032705002     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (207)

1. Agostini, I.; Navarro, J. M.; Rey, F.; Bouhamdan, M.; Spire, B.; Vigne, R.; Sire, J. The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB. J. Mol. Biol. 261:599-606; 1996.
2. Al-Harthi, L.; Roebuck, K. A. Human immunodeficiency virus type-1 transcription: Role of the 5′-untranslated leader region [review]. Int. J. Mol. Med. 1:875-881; 1998.
3. Ambrosino, C.; Ruocco, M. R.; Chen, X.; Mallardo, M.; Baudi, F.; Trematerra, S.; Quinto, I.; Venuta, S.; Scala, G. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors. J. Biol. Chem. 272:14883-14892; 1997.
4. Atwood, W. J.; Tornatore, C. S.; Traub, R.; Conant, K.; Drew, P. D.; Major, E. O. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells. AIDS Res. Hum. Retro viruses 10:1207-1211; 1994.
5. Baldwin, A. S., Jr. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14:649-683; 1996.
6. Bannister, A. J.; Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 384:641-643; 1996.
7. Barcellini, W.; Rizzardi, G. P.; Marriott, J. B.; Fain, C.; Shattock, R. J.; Meroni, P. L.; Poli, G.; Dalgleish, A. G. Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell line. AIDS 10:835-842; 1996.
8. Bassuk, A. G.; Anandappa, R. T.; Leiden, J. M. Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J. Virol. 71:3563-3573; 1997.
9. Benkirane, M.; Chun, R. F.; Xiao, H.; Ogryzko, V. V.; Howard, B. H.; Nakatani, Y.; Jeang, K. T. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 273:24898-24905; 1998.
10. Berkhout, B.; Jeang, K. T. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149; 1992.
11. Berkhout, B.; Jeang, K. T. trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: A quantitative analysis. J. Virol. 63:5501-5504; 1989.
12. Berkhout, B.; Silverman, R. H.; Jeang, K. T. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59:273-282; 1989.
13. Bielinska, A.; Krasnow, S.; Nabel, G. J. NF-kappa B-mediated activation of the human immunodeficiency virus enhancer: Site of transcriptional initiation is independent of the TATA box. J. Virol. 63:4097-4100; 1989.
14. Bieniasz, P. D.; Grdina, T. A.; Bogerd, H. P.; Cullen, B. R. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:7056-7065; 1998.
15. Biswas, D. K.; Salas, T. R.; Wang, F.; Ahlers, C. M.; Dezube, B. J.; Pardee, A. B. A Tat-induced auto-upregulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J. Virol. 69:7437-7444; 1995.
16. Bohan, C. A.; Kashanchi, F.; Ensoli, B.; Buonaguro, L.; Boris-Lawrie, K. A.; Brady, J. N. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. Gene Expr. 2:391-407; 1992.
17. Borgatti, P.; Zauli, G.; Cantley, L. C.; Capitani, S. Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and-epsilon and-zeta isoforms in PC12 cells. Biochem. Biophys. Res. Commun. 242:332-337; 1998.
18. Borgatti, P.; Zauli, G.; Colamussi, M. L.; Gibellini, D.; Previati, M.; Cantley, L. L.; Capitani, S. Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur. J. Immunol. 27:2805-2811; 1997.
19. Bradley, M. B.; Fernandez, J. M.; Ungers, G.; Diaz-Barrientos, T.; Steimle, V.; Mach, B.; Lee, J. S. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.J. Immunol. 159:1086-1095; 1997.
20. Brown, D. A.; Xu, X.; Nerenberg, M. Genomic footprinting of HTLV type I and HIV type 1 in human T cell lines. AIDS Res. Hum. Retroviruses 12:829-832; 1996.
21. Campioni, D.; Corallini, A.; Zauli, G.; Possati, L.; Altavilla, G.; Barbanti-Brodano, G. HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis. AIDS Res. Hum. Retroviruses 11:1039-1048; 1995.
22. Canonne-Hergaux, F., Aunis, D.; Schaeffer, E. Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells. J. Virol. 69:6634-6642; 1995.
23. Chang, C. H.; Flavell, R. A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765-767; 1995.
24. Chang, C. H.; Fontes, J. D.; Peterlin, M.; Flavell, R. A. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367-1374; 1994.
25. Chen, B. K.; Feinberg, M. B.; Baltimore, D. The kap-paB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J. Virol. 71:5495-5504; 1997.
26. Chun, R. F.; Jeang, J. T. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J. Biol. Chem. 271:27888-27894; 1996.
27. Chun, R. F.; Semmes, O. J.; Neuveut, C.; Jeang, J. T. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72:2615-2629; 1998.
28. Conant, K.; Atwood, W. J.; Traub, R.; Tornatore, C.; Major, E. O. An increase in p50/p65 NF:kB binding to the HIV-1 LTR is not sufficient to increase viral expression in the primary human astrocyte. Virology 205:586-590; 1994.
29. Conant, K.; Ma, M.; Nath, Major, O. E. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J. Virol. 70:1384-1389; 1996.
30. Cujec, T. P.; Cho, H.; Maldonado, E.; Meyer, J.; Reinberg, D.; Peterlin, B. M. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17:1817-1823; 1997.
31. Demarchi, F.; d'Adda di Fagagna, F.; Falaschi, A.; Giacca, M. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70:4427-4437; 1996.
32. DiDonato, J. A.; Hayakawa, M.; Rothwarf, D. M.; Zandi, E.; Karin, M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388:548-554; 1997.
33. Dinter, H.; Chiu, R.; Imagawa, M.; Karin, M.; Jones, K. A. In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter. EMBO J. 6:4067-4071; 1987.
34. Doppler, C.; Schalasta, G.; Amtmann, E.; Sauer, G. Binding of NF-κB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity. AIDS Res. Hum. Retroviruses 8:245-252; 1992.
35. Duh, E. J.; Maury, W. J.; Folks, T. M.; Fauci, A. S.; Rabson, A. B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974-5978; 1989.
36. El Kharroubi, A.; Martin, M. A. cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16:2958-2966; 1996.
37. El Kharroubi, A.; Piras, G.; Zensen, R.; Martin, M. A. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 18:2535-2544; 1998.
38. El Kharroubi, A.; Verdin, E. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem. 269:19916-19924; 1994.
39. Ensoli, B.; Buonaguro, L.; Barillari, G.; Fiorelli, V.; Gendelman, R.; Morgan, R. A.; Wingfield, P.; Gallo, R. C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:277-287; 1993.
40. 39a. Felzien, L. K.; Woffendin, C.; Hottiger, M. O.; Subbramanian, R. A.; Cohen, E. A.; Nable, G. J. HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc. Natl. Acad. Sci. USA 95:5281-5286; 1998.
41. Finnegan, A.; Roebuck, K. A.; Nakai, B. A.; Gu, D. S.; Rabbi, M. F.; Song, S.; Landay, A. L. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J. Immunol. 156:841-851; 1996.
42. Folks, T. M.; Justement, J.; Kinter, A.; Dinarello, C. A.; Fauci, A. S. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238:800-802; 1987.
43. Fontes, J. D.; Jiang, B.; Peterlin, B. M. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res. 25:2522-2528; 1997.
44. Fontes, J. D.; Kanazawa, S.; Jean, D.; Peterlin, B. M. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell. Biol. 19:941-947; 1999.
45. Fujinaga, K.; Cujec, T. P.; Peng, J.; Garriga, J.; Price, D. H.; Grana, X.; Peterlin, B. M. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72:7154-7159; 1998.
46. Garber, M. E.; Wei, P.; KewalRamani, V. N.; Mayall, T. P.; Herrmann, C. H.; Rice, A. P.; Littman, D. R.; Jones, K. A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:3512-3527; 1998.
47. Garcia-Martinez, L. F.; Mavankal, G.; Neveu, J. M.; Lane, W. S.; Ivanov, D.; Gaynor, R. B. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:2836-2850; 1997.
48. Garcia-Martinez, L. F.; Mavankal, G.; Peters, P.; Wu-Baer, F.; Gaynor, R. B. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2. J. Mol. Biol. 254:350-363; 1995.
49. Gaynor, R. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363; 1992.
50. Gerritsen, M. E.; Williams, A. J.; Neish, A. S.; Moore, S.; Shi, Y.; Collins, T. CREB-binding protein/ p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94:2927-2932; 1997.
51. Ghassemi, M.; Andersen, B. R.; Roebuck, K. A.; Rabbi, M. F.; Plate, J. M.; Novak, R. M. Mycobacterium avium complex activates nuclear factor kappaB via induction of inflammatory cytokines. Cell. Immunol. 191:117-123; 1999.
52. Gibellini, D.; Bassini, A.; Pierpaoli, S.; Bertolaso, L.; Milani, D.; Capitani, S.; La Placa, M.; Zauli, G. Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells. J. Immunol. 160:3891-3898; 1998.
53. Gibellini, D.; Caputo, A.; Capitani, S.; La Placa, M.; Zauli, G. Upregulation of c-Fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein. Blood 89:1654-1664; 1997.
54. Giese, K.; Kingsley, C.; Kirshner, J. R.; Grosschedl, R. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:995-1008; 1995.
55. Giese, K.; Pagel, J.; Grosschedl, R. Functional analysis of DNA bending and unwinding by the high mobility group domain of LEF-1. Proc. Natl. Acad. Sci. USA 94:12845-12850; 1997.
56. Gill, G.; Pascal, E.; Tseng, Z. H.; Tjian, R. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc. Natl. Acad. Sci. USA 91:192-196; 1994.
57. Goldman, P. S.; Tran, V. K.; Goodman, R. H. The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Prog. Horm. Res. 52:103-120; 1997.
58. Granowitz, E. V.; Saget, B. M.; Wang, M. Z.; Dinarello, C. A.; Skolnik, P. R. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: Blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Mol. Med. 1:667-677; 1995.
59. Guermah, M.; Malik, S.; Roeder, R. G. Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1. Mol. Cell. Biol. 18:3234-3244; 1998.
60. Hai, T.; Curran, T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720-3724; 1991.
61. Hayashi, T.; Sekine, T.; Okamoto, T. Identification of a new serine kinase that activates NF kappa B by direct phosphorylation. J. Biol. Chem. 268:26790-26795; 1993.
62. Heinemeyer, T.; Chen, X.; Karas, H.; Kel, A. E.; Kel, O. V.; Liebich, I.; Meinhardt, T.; Reuter, I.; Schach-erer, F.; Wingender, E. Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. Nucleic Acids Res. 27:318-322; 1999.
63. Heinemeyer, T.; Wingender, E.; Reuter, I.; Hermjakob, H.; Kel, H. E.; Kel, O. V.; Ignatieva, E. V.; Ananko, E. A.; Podkolodnaya, O. A.; Kolpakov, F. A.; Podkolodny, N. L.; Kolchanov, N. A. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26:362-367; 1998.
64. Henderson, A. J.; Calame, K. L. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc. Natl. Acad. Sci. USA 94:8714-8719; 1997.
65. Henderson, A. J.; Connor, R. I.; Calame, K. L. C/ EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5:91-101; 1996.
66. Henderson, A. J.; Zou, X.; Calame, K. L. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69:5337-5344; 1995.
67. Hofman, F. M.; Wright, A. D.; Dohadwala, M. M.; Wong-Staal, F.; Walker, S. M. Exogenous tat protein activates human endothelial cells. Blood 82:2774-2780; 1993.
68. Hromas, R.; Davis, B.; Rauscher, F. J., 3rd; Klemsz, M.; Tenen, D.; Hoffman, S.; Xu, D.; Morris, J. F. Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1. Curr. Top. Microbiol. Immunol. 211:159-164; 1996.
69. Huang, L.; Bosch, I.; Hofmann, W.; Sodroski, J.; Pardee, A. B. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J. Virol. 72:8952-8960; 1998.
70. Huang, L.; Li, C. J.; Pardee, A. B. Human immunodeficiency virus type 1 TAT protein activates B lymphocytes. Biochem. Biophys. Res. Commun. 237:461-464; 1997.
71. Huang, L. M.; Jeang, K. T. Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: Implication for Tat function. J. Virol. 67:6937-6944; 1993.
72. Imataka, H.; Mizuno, A.; Fujii-Kuriyama, Y.; Hayami, M. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor. AIDS Res. Hum. Retroviruses 9:825-831; 1993.
73. Israel, N.; Kazan, U.; Alcami, J.; Munier, A.; Arenzana-Seisdedos, F.; Bachelerie, F.; Israel, A.; Virelizier, J. L. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. J. Immunol. 143:3956-3960; 1989.
74. Jeang, K. T. Tat, Tat-associated kinase, and transcription. J. Biomed. Sci. 5:24-27; 1998.
75. Jeang, K. T.; Chun, R.; Lin, N. H.; Gatignol, A.; Glabe, C. G.; Fan, H. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67:6224-6233; 1993.
76. Jones, K. A. Tat and the HIV-1 promoter. Curr. Opin. Cell Biol. 5:461-468; 1993.
77. Jones, K. A.; Kadonaga, J. T.; Luciw, P. A.; Tjian, R. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232:755-759; 1986.
78. Jones, K. A.; Luciw, P. A.; Duchange, N. Structural arrangements of transcription control domains within the 5′-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev. 2:1101-1114; 1988.
79. Jones, K. A.; Peterlin, B. M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743; 1994.
80. Kagnoff, M. F.; Roebuck, K. A. Human immunodeficiency virus type 1 (HIV-1) infection and expression in intestinal epithelial cells: Role of protein kinase A and C pathways in HIV-1 transcription. J. Infect. Dis. 179:5444-447; 1998.
81. Kamine, J.; Chinnadurai, G. Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J. Virol. 66:3932-3936; 1992.
82. Kao, S. Y.; Calman, A. F.; Luciw, P. A.; Peterlin, B. M. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489-4193; 1987.
83. Karin, M.; Liu, Z.; Zandi, E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240-246; 1997.
84. Kashanchi, F.; Khleif, S. N.; Duvall, J. F.; Sadaie, M. R.; Radonovich, M. F.; Cho, M.; Martin, M. A.; Chen, S. Y.; Weinmann, R.; Brady, J. N. Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex. J. Virol. 70:5503-5510; 1996.
85. Kashanchi, F.; Piras, G.; Radonovich, M. F.; Duvall, J. F.; Fattaey, A.; Chiang, C. M.; Roeder, R. G.; Brady, J. N. Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature 367:295-299; 1994.
86. Kato, H.; Horikoshi, M.; Roeder, R. G. Repression of HIV-1 transcription by a cellular protein. Science 251:1476-1479; 1991.
87. Kato, H.; Sumimoto, H.; Pognonec, P.; Chen, C. H.; Rosen, C. A.; Roeder, R. G. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:655-666; 1992.
88. Keen, N. J.; Churcher, M. J.; Karn, J. Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 16:5260-5272; 1997.
89. Keen, N. J.; Gait, M. J.; Karn, J. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. USA 93:2505-2510; 1996.
90. Kingsman, S. M.; Kingsman, A. J. The regulation of human immunodeficiency virus type-1 gene expression. Eur. J. Biochem. 240:491-507; 1996.
91. Kino, T.; Gragerov, A.; Kopp, J. B.; Stauber, R. H.; Pavlakis, G. N.; Chrousos, G. P. The HIV-1 virionassociated protein vpr is a coactivator of the human glucocorticoid receptor. J. Exp. Med. 189:51-62; 1999.
92. Kolson, D. L.; Collman, R.; Hrin, R.; Balliet, J. W.; Laughlin, M.; McGann, K. A.; Debouck, C.; Gonzalez-Scarano, F. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: Uptake and trans-activation. J. Gen. Virol. 75:1927-1934; 1994.
93. Krasnow, S. W.; Zhang, L. Q.; Leung, K. Y.; Osborn, L.; Kunkel, S.; Nabel, G. J. Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells. Cytokine 3:372-379; 1991.
94. Kretsovali, A.; Agalioti, T.; Spilianakis, C.; Tzortzakaki, E.; Merika, M.; Papamatheakis, J. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell. Biol. 18:6777-6783; 1998.
95. Kretzschmar, M.; Meisterernst, M.; Scheidereit, C.; Li, G.; Roeder, R. G. Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. Genes Dev. 6:761-774; 1992.
96. Kumar, A.; Manna, S. K.; Dhawan, S.; Aggarwal, B. B. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J. Immunol. 161:776-781; 1998.
97. Kundu, M.; Srinivasan, A.; Pomerantz, R. J.; Khalili, K. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter. J. Virol. 69:6940-6946; 1995.
98. Leonard, J.; Parrott, C.; Buckler-White, A. J.; Turner, W.; Ross, E. K.; Martin, M. A.; Rabson, A. B. The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J. Virol. 63:4919-41924; 1989.
99. Li, J. M.; Shen, X.; Hu, P. P.; Wang, X. F. Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity. Mol. Cell. Biol. 18:110-121; 1998.
100. Li, Q.; Gebhard, K.; Schacker, T.; Henry, K.; Haase, A. T. The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissue. J. Virol. 71:7080-7082; 1997.
101. Li, X.; Liang, C.; Quan, Y.; Chandok, R.; Laughrea, M.; Parniak, M. A.; Kleiman, L.; Wainberg, M. A. Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1. J. Virol. 71:6003-6010; 1997.
102. Li, X.; Quan, Y.; Wainberg, M. A. Controlling elements in replication of the human immunodeficiency virus type 1. Cell. Mol. Biol. 43:443-454; 1997.
103. Li, X. Y.; Green, M. R. The HIV-1 Tat cellular coact-ivator Tat-SF1 is a general transcription elongation factor. Genes Dev. 12:2992-2996; 1998.
104. Liang, C.; Li, X.; Quan, Y.; Laughrea, M.; Kleiman, L.; Hiscott, J.; Wainberg, M. A. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription. J. Mol. Biol. 272:167-177; 1997.
105. Liu, J.; Perkins, N. D.; Schmid, R. M.; Nabel, G. J. Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J. Virol. 66:3883-3887; 1992.
106. Liu, Y.; Su, C.; Garcia-Blanco, M. A. Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex. Virology 255:337-346; 1999.
107. Liu, Y. Z.; Latchman, D. S. The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat. Biochem. J. 322:155-158; 1997.
108. Lodie, T. A.; Reiner, M.; Coniglio, S.; Viglianti, G.; Fenton, M. J. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide-induced HIV-1 long terminal repeat transcription in macrophages. J. Immunol. 161:268-276; 1998.
109. Love, J. J.; Li, X.; Case, D. A.; Giese, K.; Grosschedl, R.; Wright, P. E. Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376:791-795; 1995.
110. Lu, X.; Welsh, T. M.; Peterlin, B. M. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat. J. Virol. 67:1752-1760; 1993.
111. Lu, Y. C.; Touzjian, N.; Stenzel, M.; Dorfman, T.; Sodroski, J. G.; Haseltine, W. A. Identification of cisacting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1. J. Virol. 64:5226-5229; 1990.
112. Majello, B.; De Luca, P.; Hagen, G.; Suske, G.; Lania, L. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:4914-4921; 1994.
113. Majello, B.; Napolitano, G.; De Luca, P.; Lania, L. Recruitment of human TBP selectively activates RNA polymerase II TATA-dependent promoters. J. Biol. Chem. 273:16509-16516; 1998.
114. Majello, B.; Napolitano, G.; Lania, L. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation. AIDS 12:1957-1964; 1998.
115. Malim, M. H.; Fenrick, R.; Ballard, D. W.; Hauber, J.; Bohnlein, E.; Cullen, B. R. Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region. J. Virol. 63:3213-3219; 1989.
116. Mallardo, M.; Dragonetti, E.; Baldassarre, F.; Ambrosino, C.; Scala, G.; Quinto, I. An NF-kappaB site in the 5′-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli. J. Biol. Chem. 271:20820-20827; 1996.
117. Margolis, D. M.; Ostrove, J. M.; Straus, S. E. HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element. Virology 192:370-374; 1993.
118. Margolis, D. M.; Somasundaran, M.; Green, M. R. Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production. J. Virol. 68:905-910; 1994.
119. Markovitz, D. M.; Hannibal, M. C.; Smith, M. J.; Cossman, R.; Nabel, G. J. Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1. J. Virol. 66:3961-3965; 1992.
120. Marzio, G.; Tyagi, M.; Gutierrez, M. I.; Giacca, M. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. USA 95:13519-13524; 1998.
121. Mellors, J. W.; Griffith, B. P.; Ortiz, M. A.; Landry, M. L.; Ryan, J. L. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiencyvirus type 1 replication in primary macrophages. J. Infect. Dis. 163:78-82; 1991.
122. Mercurio,' F.; Zhu, H.; Murray, B. W.; Shevchenko, A.; Bennett, B. L.; Li, J.; Young, D. B.; Barbosa, M.; Mann, M.; Manning, A.; Rao, A. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NFkappaB activation. Science 278:860-866; 1997.
123. Milani, D.; Mazzoni, M.; Borgatti, P.; Zauli, G.; Cantley, L.; Capitani, S. Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells. J. Biol. Chem. 271:22961-22964; 1996.
124. Mirkovitch, J. The role of chromatin in HIV-1 transcriptional regulation. Immunobiology 198:279-290; 1997.
125. Mondal, D.; Alam, J.; Prakash, O. NF-kappa B sitemediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells. J. Mol. Neurosci. 5:241-258; 1994.
126. Montano, M. A.; Kripke, K.; Norina, C. D.; Achacoso, P.; Herzenberg, L. A.; Roy, A. L.; Nolan, G. P. NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I. Proc. Natl. Acad. Sci. USA 93:12376-12381; 1996.
127. Moreno, C. S.; Beresford, G. W.; Louis-Plence, P.; Morris, A. C.; Boss, J. M. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10:143-151; 1999.
128. Morris, J. F.; Hromas, R.; Rauscher, R. J., 3rd. Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: Two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core. Mol. Cell. Biol. 14:1786-1795; 1994.
129. Morrison, D. J.; Pendergrast, P. S.; Stavropoulos, P.; Colmenares, S. U.; Kobayashi, R.; Hemandez, N. FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res. 27:1251-1262; 1999.
130. Navarro, J.; Punzon, C.; Jimenez, J. L.; Fernandez-Cruz, E.; Pizarro, A.; Fresno, M.; Munoz-Fernandez, M. A. Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: Involvement of NF-kappaB and NFAT. J. Virol. 72:4712-4720; 1998.
131. Ng, K. W.; Ridgway, P.; Cohen, D. R.; Tremethick, D. J. The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome. EMBO J. 16:2072-2085; 1997.
132. Ogryzko, V. V.; Schuiltz, R. L.; Russanova, V.; Howard, B. H.; Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959; 1996.
133. Ohana, B.; Moore, P. A.; Ruben, S. M.; Southgate, C. D.; Green, M. R.; Rosen, C. A. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes. Proc. Natl. Acad. Sci. USA 90:138-142; 1993.
134. Okamoto, H.; Sheline, C. T.; Corden, J. L.; Jones, K. A.; Peterlin, B. M. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. USA 93:11575-11579; 1996.
135. Okamoto, T.; Matsuyama, T.; Mon, S.; Hamamoto, Y.; Kobayashi, N.; Yamamoto, N.; Josephs, S. F.; Wong-Staal, F.; Shimotohno, K. Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. AIDS Res. Hum. Retroviruses 5:131-138; 1989.
136. Olsen, H. S.; Rosen, C. A. Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J. Virol. 66:5594-5597; 1992.
137. Opalenik, S. R.; Shin, J. T.; Wehby, J. N.; Mahesh, V. K.; Thompson, J. A. The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibroblast growth factor. J. Biol. Chem. 270:17457-17467; 1995.
138. Ott, M.; Lovett, J. L.; Mueller, L.; Verdin, E. Super-induction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors. J. Immunol. 160:2872-2880; 1998.
139. Parada, C. A.; Roeder, R. G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384:375-378; 1996.
140. Parada, C. A.; Yoon, J. B.; Roeder, R. G. A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro. J. Biol. Chem. 270:2274-2283; 1995.
141. Pazin, M. J.; Sheridan, P. L.; Cannon, K.; Cao, Z.; Keck, J. G.; Kadonaga, J. T.; Jones, K. A. NF-kappa B-mediated chromatin reconfiguration and transcrip-tional activation of the HIV-1 enhancer in vitro. Genes Dev. 10:37-419; 1996.
142. Pendergrast, P. S.; Morrison, D.; Tansey, W. P.; Hernandez, N. Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly. J. Virol. 70:5025-5034; 1996.
143. Perkins, N. D.; Agranoff, A. B.; Pascal, E.; Nabel, G. J. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol. Cell. Biol. 14:6570-6583; 1994.
144. Perkins, N. D.; Edwards, N. L.; Duckett, C. S.; Agranoff, A. B.; Schmid, R. M.; Nabel, G. J. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12:3551-3558; 1993.
145. Pessler, F.; Pendergrast, P. S.; Hernandez, N. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol. Cell. Biol. 17:3786-3798; 1997.
146. Ping, Y. H.; Rana, T. M. Tat-associated kinase (PTEFb): A component of transcription preinitiation and elongation complexes. J. Biol. Chem. 274:7399-7404; 1999.
147. Poli, G.; Bressler, P.; Kinter, A.; Duh, E.; Timmer, W. C.; Rabson, A.; Justement, J. S.; Stanley, S.; Fauci, A. S. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172:151-158; 1990.
148. Rabbi, M. F.; Al-Harthi, L.; Roebuck, K. A. TNFalpha cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements. Virology 237:422-4429; 1997.
149. Rabbi, M. F.; Al-Harthi, L.; Saifuddin, M.; Roebuck, K. A. The cAMP-dependent protein kinase A and protein kinase C pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage. Virology 245:257-269; 1998.
150. Rabbi, M. F.; Saifuddin, M.; Gu, D. S.; Kagnoff, M. F.; Roebuck, K. A. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins. Virology 233:235-245; 1997.
151. Rahman, A.; Esmaili, A.; Saatcioglu, F. A unique thyroid hormone response element in the human immunodeficiency virus type 1 long terminal repeat that overlaps the Sp1 binding sites. J. Biol. Chem. 270:31059-31064; 1995.
152. Rao, A.; Luo, C.; Hogan, P. G. Transcription factors of the NFAT family: Regulation and function. Annu. Rev. Immunol. 15:707-747; 1997.
153. Riley, J. L.; Westerheide, S. D.; Price, J. A.; Brown, J. A.; Boss, J. M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533-543; 1995.
154. Rittner, K.; Churcher, M. J.; Gait, M. J.; Karn, J. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. J. Mol. Biol. 248:562-580; 1995.
155. Roebuck, K. A.; Brenner, D. A.; Kagnoff, M. F. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J. Clin. Invest. 92:1336-1348; 1993.
156. Roebuck, K. A.; Gu, D. S.; Kagnoff, M. F. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS 10:819-826; 1996.
157. Roebuck, K. A.; Rabbi, M. F.; Kagnoff, M. F. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element. AIDS 11:139-146; 1997.
158. Romerio, F.; Gabriel, M. N.; Margolis, D. M. Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF. J. Virol. 71:9375-9382; 1997.
159. Ruocco, M. R.; Chen, X.; Ambrosino, C.; Dragonetti, E.; Liu, W.; Mallardo, M.; De Falco, G.; Palmieri, C.; Franzoso, G.; Quinto, I.; Venuta, S.; Scala, G. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors. J. Biol. Chem. 271:22479-22486; 1996.
160. Saluja, D.; Vassallo, M. F.; Tanese, N. Distinct sub-domains of human TAFII130 are required for interactions with glutamine-rich transcriptional activators. Mol. Cell. Biol. 18:5734-8743; 1998.
161. Schmitz, M. L.; Baeuerle, P. A. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 10:3805-3817; 1991.
162. Schmitz, M. L.; Stelzer, G.; Altmann, H.; Meisterernst, M.; Baeuerle, P. A. Interaction of the COOHterminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators. J. Biol. Chem. 270:7219-7226; 1995.
163. Secchiero, P.; Zella, D.; Capitani, S.; Gallo, R. C.; Zauli, G. Extracellular HIV-1 Tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. J. Immunol. 162:2427-2431; 1999.
164. Selby, M. J.; Bain, E. S.; Luciw, P. A.; Peterlin, B. M. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 3:547-558; 1989.
165. Sheldon, M.; Ratnasabapathy, R.; Hernandez, N. Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol. Cell. Biol. 13:1251-1263; 1993.
166. Sheridan, P. L.; Mayall, T. P.; Verdin, E.; Jones, K. A. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev. 11:3327-3340; 1997.
167. Sheridan, P. L.; Sheline, C. T.; Cannon, K.; Voz, M. L.; Pazin, M. J.; Kadonaga, J. T.; Jones, K. A. Activation of the HIV-1 enhancer by the LEF-I HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9:2090-2104; 1995.
168. Southgate, C. D.; Green, M. R. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: Implications for Tat function. Genes Dev. 5:2496-2507; 1991.
169. Steger, D. J.; Eberharter, A.; John, S.; Grant, P. A.; Workman, J. L. Purified histone acetyltransferase complexes stimulate HIV-1 transcription from preassembled nucleosomal arrays. Proc. Natl. Acad. Sci. USA 95:12924-12929; 1998.
170. Steger, D. J.; Workman, J. L. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. EMBO J. 16:2463-2472; 1997.
171. Steimle, V.; Otten, L. A.; Zufferey, M.; Mach, B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146; 1993.
172. Stein, B.; Baldwin, A. S., Jr.; Ballard, D. W.; Greene, W. C.; Angel, P.; Herrlich, P. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879-3891; 1993.
173. Stein, B.; Cogswell, P. C.; Baldwin, A. S., Jr. Functional and physical associations between NF-kappa B and C/EBP family members: A Rel domain-bZIP interaction. Mol. Cell. Biol. 13:3964-3974; 1993.
174. Subbramanian, R. A.; Kessous-Elbaz, A.; Lodge, R.; Forget, J.; Yao, X. J.; Bergeron, D.; Cohen, E. A. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J. Exp. Med. 187:1103-1111; 1998.
175. Subler, M. A.; Martin, D. W.; Deb, S. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53. J. Virol. 68:103-110; 1994.
176. Sun, L. J.; Peterson, B. R.; Verdine, G. L. Dual role of the nuclear factor of activated T cells insert region in DNA recognition and cooperative contacts to activator protein 1. Proc. Natl. Acad. Sci. USA 94:4919-4924; 1997.
177. Sune, C.; Garcia-Blanco, M. A. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 69:6572-6576; 1995.
178. Sune, C.; Garcia-Blanco, M. A. Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. J. Virol. 69:3098-3107; 1995.
179. Tanaka, T.; Nakamura, T.; Takagi, H.; Sato, M. Mo-lecular cloning and characterization of a novel TBP-1 interacting protein (TBPIP): Enhancement of TBP-1 action on Tat by TBPIP. Biochem. Biophys. Res. Commun. 239:176-181; 1997.
180. Tesmer, V. M.; Bina, M. Regulation of HIV-1 gene expression by NF-IL6. J. Mol. Biol. 262:327-335; 1996.
181. Tesmer, V. M.; Rajadhyaksha, A.; Babin, J.; Bina, M. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:7298-7302; 1993.
182. Toohey, M. G.; Jones, K. A. In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions. Genes Dev. 3:265-282; 1989.
183. van Dam, H.; Duyndam, M.; Rottier, R.; Bosch, A.; de Vries-Smits, L.; Herrlich, P.; Zantema, A.; Angel, P.; van der Eb, A. J. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12:479-487; 1993.
184. Van Lint, C.; Amella, C. A.; Emiliani, S.; John, M.; Jie, T.; Verdin, E. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol. 71:6113-6127; 1997.
185. Van Lint, C.; Emiliani, S.; Ott, M.; Verdin, E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15:1112-1120; 1996.
186. Verdin, E. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J. Virol. 65:6790-6799; 1991.
187. Verdin, E.; Paras, P., Jr.; Van Lint, C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12:3249-3259; 1993.
188. Verrijzer, C. P.; Tjian, R. TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem. Sci. 21:338-342; 1996.
189. Veschambre, P.; Simard, P.; Jalinot, P. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J. Mol. Biol. 250:169-180; 1995.
190. Wang, L.; Mukherjee, S.; Jia, F.; Narayan, O.; Zhao, L. J. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and Irans-activation of viral long terminal repeat. J. Biol. Chem. 270:25564-25569; 1995.
191. Wei, P.; Garber, M. E.; Fang, S. M.; Fischer, W. H.; Jones, K. A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462; 1998.
192. West, M.; Mikovits, J.; Princier, G.; Liu, Y. L.; Ruscetti, F. W.; Kung, H. F.; Raziuddin, A. Characteriza-tion and purification of a novel transcriptional repressoer from HeLa cell nuclear extracts recognizing the negative regulatory element region of human immunodeficiency vinis-1 long terminal repeat. J. Biol. Chem. 267:24948-24952; 1992.
193. West, M. J.; Karn, J. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer. EMBO J. 18:1378-1386; 1999.
194. Westendorp, M. O.; Li-Weber, M.; Frank, R. W.; Krammer, P. H. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68:4177-4185; 1994.
195. Widlak, P.; Garrard, W. T. Nucleosomes and regulation of gene expression. Structure of the HIV-1 5′LTR. Acta Biochim. Pol. 45:209-219; 1998.
196. Widlak, P.; Gaynor, R. B.; Garrard, W. T. In vitro chromatin assembly of the HIV-1 promoter. ATP-dependent polar repositioning of nucleosomes by Sp1 and NFkappaB. J. Biol. Chem. 272:17654-17661; 1997.
197. Williams, R. D.; Lee, B. A.; Jackson, S. P.; Proudfoot, N. J. Activation domains of transcription factors mediate replication dependent transcription from a minimal HIV-1 promoter. Nucleic Acids Res. 24:549-557; 1996.
198. Wu, B. Y.; Woffendin, C.; MacLachlan, I.; Nabel, G. J. Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev. J. Virol. 71:3161-3167; 1997.
199. Wu-Baer, F.; Sigman, D.; Gaynor, R. B. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc. Natl. Acad. Sci. USA 92:7153-7157; 1995.
200. Xiao, H.; Lis, J. T.; Jeang, K. T. Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment. Mol. Cell. Biol. 17:6898-6905; 1997.
201. Yu, L.; Zhang, Z.; Loewenstein, P. M.; Desai, K.; Tang, Q.; Mao, D.; Symington, J. S.; Green, M. Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain. J. Virol. 69:3007-3016; 1995.
202. Zauli, G.; Previati, M.; Caramelli, E.; Bassini, A.; Falcieri, E.; Gibellini, D.; Bertolaso, L.; Bosco, D.; Robuffo, I.; Capitani, S. Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line. Eur. J. Immunol. 25:2695-2700; 1995.
203. Zenzie-Gregory, B.; Sheridan, P.; Jones, K. A.; Smale, S. T. HIV-1 core promoter lacks a simple initiator element but contains a bipartite activator at the transcription start site. J. Biol. Chem. 268:15823-15832; 1993.
204. Zhou, H.; Glimcher, L. H. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545-553; 1995.
205. Zhou, Q.; Chen, D.; Pierstorff, E.; Luo, K. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17:3681-3691; 1998.
206. Zhou, Q.; Sharp, P. A. Tat-SF1: Cofactor for stimulation of transcriptional elongation by HIV-I Tat. Science 274:605-610; 1996.
207. Zhu, Y.; Pe'ery, T.; Peng, J.; Ramanathan, Y.; Marshall, N.; Marshall, T.; Amendt, B.; Mathews, M. B.; Price, D. H. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:2622-2632; 1997.